Orchestra Therapeutics, Inc.

Indentures Filter

EX-4.6
from 8-A12G/A 5 pages Amendment No. 5 to Rights Agreement
12/34/56
EX-4.1
from 10-K 15 pages Certificate of Designation of Rights and Preferences of Series a Convertible Preferred Stock of the Immune Response Corporation
12/34/56
EX-4.5
from 8-A12G/A 4 pages Amendment No. 4 to Rights Agreement
12/34/56
EX-4.2
from S-3 ~50 pages Warrant Agreement by and Between the Immune Response Corporation and Computershare Trust Company, Inc. as Warrant Agent Dated as of December 10, 2002
12/34/56
EX-4.4
from 8-A12G/A 1 page Amendment No. 3 to Rights Agreement
12/34/56
EX-4.3
from 8-K ~10 pages Warrant Agreement
12/34/56
EX-4.2
from 8-K 1 page The Securities Represented Hereby Have Been Issued Without Registration Under the Securities Act of 1933, as Amended, or Under Any State Securities Laws, and May Not Be Sold, Transferred or Pledged in the Absence of an Effective Registration Statement Under Applicable Federal and State Securities Laws or an Opinion of Counsel Reasonably Satisfactory to the Company That the Transfer Is Exempt From Registration Under Applicable Federal and State Securities Laws
12/34/56
EX-4.1
from 8-K ~5 pages Amendment No. 1 to Note Purchase Agreement
12/34/56
EX-4.3
from 8-A12G/A ~1 page Amendment No. 2 to Rights Agreement
12/34/56
EX-4.2
from 8-A12G/A 1 page Amendment No. 1 to Rights Agreement
12/34/56
EX-4.3
from 8-K ~10 pages Indenture or similar
12/34/56
EX-4.2
from 8-K 1 page Indenture or similar
12/34/56
EX-4.1
from 8-K ~20 pages Indenture or similar
12/34/56
EX-4
from SC 13D ~5 pages Indenture or similar
12/34/56